Catherine Mace;Christian Darlmont;Chieh Jason Chou;Fabrizio Arigoni;David Philippe
发明人:
Chieh Jason Chou,David Philippe,Christian Darlmont,Fabrizio Arigoni,Catherine Mace
申请号：
US12673891
公开号：
US08591880B2
申请日:
2008.07.25
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria； and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.
